Definium Therapeutics, Inc. - Common Shares (DFTX)
NASDAQ · Healthcare
$42.80-3.36%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $4.85B
- P/E ratio
- —
- EPS
- —
- Volume
- 1,221,632
- 52-week high
- —
- 52-week low
- —
- Open
- $43.85
- Day high
- $45.31
- Day low
- $42.75
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$183.79M | -$2.06 |
| 2024 | — | -$108.68M | -$1.54 |
| 2023 | — | -$95.73M | -$2.44 |
| 2022 | — | -$56.8M | -$1.84 |
| 2021 | — | -$93.04M | -$3.40 |
About Definium Therapeutics, Inc. - Common Shares
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.
- CEO
- Robert Barrow
- Employees
- 74
- Country
- US
- IPO date
- Nov 15, 2016
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Definium Therapeutics, Inc. - Common Shares's stock price today?
- DFTX is trading at $42.80 as of Jul 20, 2026.
- What is Definium Therapeutics, Inc. - Common Shares's market cap?
- Definium Therapeutics, Inc. - Common Shares (DFTX) has a market capitalization of $4.85B.
- Does Definium Therapeutics, Inc. - Common Shares pay a dividend?
- Definium Therapeutics, Inc. - Common Shares did not pay a dividend in its most recent reported fiscal year.
- What sector is Definium Therapeutics, Inc. - Common Shares in?
- Definium Therapeutics, Inc. - Common Shares operates in the Healthcare sector.